HCA Healthcare（HCA）FY2025年报排雷报告

框架：唐朝《手把手教你读财报》+ Schilit《Financial Shenanigans》+ Beneish M-Score

核心理念："财报是用来排除企业的"

数据来源：SEC EDGAR 10-K原文 + Yahoo Finance

❌ 评级F——债务覆盖率出现重大红旗

一句话：HCA的F评级几乎完全由一项关键检查驱动——$10.4亿现金仅能覆盖$487亿债务堆的2%——再叠加$-60.3亿的股东权益为负。其余筛选项出奇地干净：DSO改善3天、CFFO/NI比率1.86、自由现金流达到$76.9亿、应计深度为负。HCA是回购融资型资本结构的教科书案例：仅FY2025公司就通过回购向股东返还了$100.7亿，机械地把权益推为负值，而现金流引擎仍在运转。这是一份关于财务激进但运营健康的医院运营商的盈利质量报告。

一、美国最大的私营医院运营商

10-K原文："HCA Healthcare, Inc. is one of the leading health care services companies in the United States. At December 31, 2025, we operated 190 hospitals, comprised of 179 general acute care hospitals, seven behavioral hospitals, and four rehabilitation hospitals. In addition, we operated 121 freestanding ambulatory surgery centers (ASCs) and 31 freestanding endoscopy centers. Our facilities are located in 19 states and England."

FY2025营收$756亿让HCA成为全美最大的投资者拥有的医院运营商。业务集中在高增长的阳光地带市场——仅佛罗里达州就有47家医院和13,384张床位。

FY2025营收增长7.1%，营业利润增长13.3%，净利润增长17.7%——典型的运营杠杆：固定成本被更高的业务量摊薄。毛利率扩张90个基点是健康的信号，说明定价和成本管理协同起效。

收入结构：几乎全部来自第三方支付方

收入来自Medicare、Medicaid、管理式医疗和商业保险的复杂组合。EY的第一项关键审计事项正是针对这种复杂性："revenues are based upon the estimated amounts the Company expects to be entitled to receive from patients and third-party payers. Estimates of contractual adjustments under managed care and commercial insurance plans and government payor programs are based upon the payment terms specified in the related contractual agreements or provided by government payor programs."

二、资产负债表：回购融资型资本结构

HCA资产负债表的决定性特征是公司主动选择将几乎全部盈利返还给股东。10-K流动性与资本资源章节："During 2025, we had a net increase of $3.287 billion in our indebtedness, paid dividends of $679 million and paid $10.067 billion for repurchases of common stock."

三年来的模式一以贯之：

后果直接体现在资产负债表上：

10-K风险因素："As of December 31, 2025, our total indebtedness was $46.492 billion. As of December 31, 2025, we had availability of $5.779 billion under our senior unsecured credit facility (after giving effect to all issued and outstanding letters of credit and our intention to maintain a minimum available borrowing capacity equal to the aggregate amount outstanding under the commercial paper program ($2.207 billion as of December 31, 2025))."

HCA的首位风险因素就是自身的债务负担："Our indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk to the extent of our variable rate debt and prevent us from meeting our obligations."

三、现金流：运营引擎仍在运转

10-K："Cash provided by operating activities totaled $12.636 billion in 2025 compared to $10.514 billion in 2024 and $9.431 billion in 2023. The $2.122 billion increase in cash provided by operating activities for 2025... was related primarily to the combined impact of a $1.319 billion increase in net income... positive changes in working capital of $524 million and a decline in income taxes paid of $104 million."

资本开支指引激进："Planned capital expenditures are expected to approximate between $5.0 billion and $5.5 billion in 2026. At December 31, 2025, there were projects under construction which had an estimated additional cost to complete and equip over the next five years of approximately $7.1 billion."

四、18项排雷检查

收入质量

三项收入质量检查全部通过。DSO改善3天，应收只增长1.1%而营收增长7.1%，CFFO增速是营收的近三倍——健康收入质量的教科书信号。

费用质量

现金流质量

C4是驱动F评级的关键失败项。 $10.4亿现金对$487亿总债务，覆盖率仅2%。然而背景很重要：HCA在高级无担保信贷额度下有$57.8亿可用，其中$22.1亿用于支持商业票据。2%的覆盖率看上去极端，但反映的是一家年产$126亿经营现金流的公司的主动现金管理策略。

其他方面的经营现金流质量都很优秀：CFFO/NI 1.86远高于1.0，FCF $76.9亿足以覆盖分红并有富余，应计比率-9.6%深度保守。

资产负债表

债务/EBITDA 3.1x（$487亿债务对$156亿EBITDA）在大型医院运营商的正常区间内。商誉线在数据中显示为零——对HCA这样体量的公司来说不寻常，但反映了其主要依靠内生增长、近期没有大型并购的事实。

并购风险

10-K："We expended $397 million, $266 million and $635 million for acquisitions of hospitals and health care entities during 2025, 2024 and 2023, respectively." 只有小规模补强收购。

Beneish M-Score

五、10-K原文中的关键风险

1. 杠杆和再融资风险（首位风险）。 10-K："We have significant indebtedness and may incur further indebtedness in the future. Our indebtedness could adversely affect our ability to raise additional capital... prevent us from meeting our obligations." 10-K警告："We cannot guarantee we will maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness."

2. 政府报销风险（Medicare、Medicaid以及2025年联邦预算法案）。 HCA的前瞻性声明列出："possible reductions or other changes in Medicare, Medicaid and other state programs, including Medicaid supplemental payment programs, Medicaid waiver programs and state directed payment arrangements." 10-K还特别提到"the expiration at the end of 2025 of enhanced premium tax credits (EPTCs) for eligible individuals purchasing insurance coverage through federal and state-based health insurance marketplaces"——直接打击交易所覆盖的患者基数。

3. 劳动力成本和护士排班法规。 10-K讨论了强制护士配比："We operate in states that have adopted mandatory nurse-staffing ratios or mandate staffing committees to develop staffing plans. If these states reduce, or if additional states in which we operate adopt or the federal government adopts, mandatory nurse-staffing ratios or related measures, our compliance with such measures could significantly affect labor costs."

4. 收入确认估计（第一项关键审计事项）。 EY指出收入确认的复杂性："Auditing management's estimates of contractual adjustments and implicit price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in determining related amounts." 风险敞口巨大，因为医院确认的收入是扣除估计合同调整和价格让步后的净额，而这些数月或数年后才能结清。

5. 职业责任准备金（第二项关键审计事项）。 审计师报告："At December 31, 2025, the Company's reserves for professional liability risks were $2.044 billion and the Company's related provision for losses for the year ended December 31, 2025 was $651 million."

六、Altman Z-Score和F-Score

Altman Z-Score 0.87位于困境区域。然而这完全由负的股东权益驱动——是回购战略的直接后果，而非运营恶化。一家年产$126亿CFFO、主动通过回购把权益推为负的公司，不是Altman模型设计用来标记的对象。Z-Score准确捕捉了资产负债表杠杆，但误判了整体财务健康。F-Score 0.65确认了低错报风险。

七、总结

评级：F。单一关键失败项（现金 vs 债务）加上负的股东权益压倒了十五项通过的检查。

HCA的F评级几乎完全是其资本返还战略的函数。公司年产$126亿经营现金流，选择通过回购向股东返还$100.7亿（仅FY2025），由增量借债支持。十八项筛选中十五项通过——收入质量、费用纪律、应计、杠杆、商誉、现金流全部干净。唯一的关键失败是机械性的：$10.4亿现金对$487亿债务产生2%的覆盖率，触发筛选阈值，尽管$57.8亿的未动用信贷额度提供了真实的缓冲。

真正的盈利质量信号都是正面的：DSO收紧3天、CFFO在7%营收增长上增长20%、FCF扩张36%到$76.9亿、毛利率扩张90个基点。这是一个运营健康的业务。F评级标记的是财务工程，不是底层医院业务。

财报是起点，不是终点。

⚠️ **免责声明**：本报告基于HCA Healthcare 2025 10-K年报原文（SEC EDGAR）及Yahoo Finance公开财务数据，运用排雷框架进行分析，不构成任何投资建议。投资有风险，决策需自行判断。

数据来源：SEC EDGAR 10-K (Filed 2026-02-10) + Yahoo Finance

审计师：Ernst & Young LLP（无保留意见，2项关键审计事项）